Administration of raloxifene hydrochloride nanosuspensions partially attenuates bone loss in ovariectomized mice-Reference-Cited by-同舟云学术

Administration of raloxifene hydrochloride nanosuspensions partially attenuates bone loss in ovariectomized mice

Published:2018 Issue:42 Volume:8 Page:23748-23756
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Han Meihua¹²³⁴⁵^ORCID,Qi Xiaoyu¹²³⁴⁵,Bi Dongdong¹²³⁴⁵^ORCID,Li Yijing¹²³⁴⁵,Guo Yifei¹²³⁴⁵^ORCID,Wang Xiangtao¹²³⁴⁵,Feng Li⁶⁷⁸⁵

Affiliation:

1. Institute of Medicinal Plant Development

2. Chinese Academy of Medical Sciences

3. Peking Union Medical College

4. Beijing 100193

5. China

6. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital

7. Chinese Academy of Medical Sciences and Peking Union Medical College

8. Beijing

Abstract

RLX-NSps could partially attenuate bone loss more effectively than RLX solution in OVX mice by inhibiting bone resorption and improving the ability of BMSCs to proliferate and their osteogenic differentiation to some extent.

Funder

National Natural Science Foundation of China

Beijing Municipal Science and Technology Commission

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/RA/C8RA02535E

Reference38 articles.

1. Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis

2. Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment

3. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis

4. The effect of whole-body vibration therapy on bone metabolism, motor function, and anthropometric parameters in women with postmenopausal osteoporosis

5. Less frequent dosing of bisphosphonates in osteoporosis: focus on ibandronate

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanosuspensions in ophthalmology: Overcoming challenges and enhancing drug delivery for eye diseases;International Journal of Pharmaceutics;2024-06

2. Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene;International Journal of Pharmaceutics;2020-10